RT Journal Article
SR Electronic
A1 Kuznar, Wayne
T1 Improving Outcomes of Ventilator-Associated Pneumonia
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 4
SP 26
OP 27
DO 10.1177/155989771304016
UL http://mdc.sagepub.com/content/13/4/26.abstract
AB Nosocomial pneumonia, especially ventilator-associated pneumonia (VAP), is a major cause of morbidity and mortality in the intensive care unit (ICU). This article discusses updates on bacterial resistance relevant to VAP, with a focus on methicillin-resistant Staphylococcus aureus (MRSA), treating MRSA pneumonia in the ICU, the use of tigecycline and doripenem for hospital-acquired pneumonia and VAP, and the potential utility of inhaled antibiotics as an alternative in the treatment of patients with VAP.